Botulinum toxin for sialorrhea in people with Parkinson's disease

The objectives of this review are to establish the efficacy and safety of BoNT aimed at reducing sialorrhea in people with PD and to provide the best evidence to inform clinical practice. Furthermore the review aims to identify clear directions for future clinical trials and intervention studies in this area.

Award Date
18 September 2014
Award Value
Principal Investigator
Ms Fiona Hill
Host Institution
Trinity College Dublin
Cochrane Training Fellowships